Ginsenoside Rg3-enriched Korean Red Ginseng extract attenuates Non-Alcoholic Fatty Liver Disease by way of suppressed VCAM-1 expression in liver sinusoidal endothelium.

Authors:
Lee SW; Baek SM; Lee YJ; Kim TU; Yim JH and 8 more

Journal:
J Ginseng Res

Publication Year: 2022

DOI:
10.1016/j.jgr.2022.10.005

PMCID:
PMC10214299

PMID:
37252282

Journal Information

Full Title: J Ginseng Res

Abbreviation: J Ginseng Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declared that they had no conflicts of interests."

Evidence found in paper:

"Funding This work was supported by the 2020 grant from 10.13039/501100015826The Korean Society of Ginseng, the 10.13039/501100010274DGIST R&D Program of the 10.13039/501100014188Ministry of Science and ICT (2020010096), and National Research Foundation of Korea (NRF) of the Ministry of Education (2019R1I1A2A01060031)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025